Research and Markets (http://www.researchandmarkets.com/research/096482/transdermal_hormon) has announced the addition of the "Transdermal Hormone Replacement: Markets, Demand Factors, Opportunities and Forecasts" report to their offering.
“Transdermal Hormone Replacement: Markets, Demand Factors, Opportunities and Forecasts”
As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue - one that is particularly problematic in aging populations and developing economies. Currently approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics. These patches and gels will encounter competition from development-stage transdermal formulations for a number of pain medications presently being marketed in oral or parenteral form. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.
Feature Summary